PHARMACOGENETIC EFFECTS OF NALTREXONE IN INDIVIDUALS OF EAST ASIAN DESCENT: HUMAN LABORATORY FINDINGS FROM A RANDOMIZED TRIAL

BACKGROUND: Genetic variation in the endogenous opioid system has been identified as one potential source of individual variability in naltrexone treatment outcomes. The majority of naltrexone pharmacogenetic studies have focused on a particular single nucleotide polymorphism (SNP) of the mu-opioid...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Alcohol Clin Exp Res
Päätekijät: Ray, Lara A., Green, ReJoyce, Roche, Daniel J.O., Bujarski, Spencer, Hartwell, Emily E., Lim, Aaron C., Rohrbaugh, Taylor, Ghahremani, Dara, Hutchison, Kent, Miotto, Karen
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2018
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6086578/
https://ncbi.nlm.nih.gov/pubmed/29265379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/acer.13586
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia